- US Capitol Capsule: Cancer Therapies, Orphan Drugs Dominated 2015 Approvals; PCSK9s Arrived
- US Capitol Capsule: 'Innovative' Value-Based Pricing Strategies: Biopharma's Savior?
- 60 Degrees Takes Dengue Treatments Forward Saying 'Vaccines Are An Imperfect Solution'
- Lupin Soars As Plant-Related Concerns Fade
- INTERVIEW: Clinuvel's Philippe Wolgen on Scenesse and the patient factor
- PROFILE: Novo's Riis Recalls First Victoza Delivery, Growing Up With Science
04 April 2016
06 April 2016
JOB OF THE WEEK Promote your job vacancy